Posts by: Alice Melão

News

Myriad Genetics has developed a new test, called riskScore, that accurately predicts the five-year and lifetime risk of breast cancer in women who tested negative for hereditary mutations in breast cancer ... Read more

December 4, 2017December 4, 2017

FDA Approves Ogivri, Biosimilar to Herceptin, to Treat HER2+ Breast Cancer

News

HER2-positive breast cancer patients in the U.S. will have the possibility of being treated with a biosimilar to Herceptin (trastuzumab), following the approval of Ogivri (trastuzumab-dkst) as a more affordable ... Read more

December 1, 2017December 1, 2017

New Guidelines for Advanced Breast Cancer Treatment Discussed at ABC 4 Conference

News

Clinical trials for hormone-dependent advanced breast cancer should be less restrictive in the criteria used to determine who can participate, and they should allow pre-menopausal women — who account for a ... Read more

November 29, 2017

Exercise Improves Advanced Breast Cancer Patients’ Heart Function, Quality of Life, Study Shows

News

Tailored exercise plans that include aerobic and resistance training can benefit patients with advanced breast cancer, improving their heart function and quality of life while reducing their fatigue and pain, a ... Read more

October 30, 2017October 30, 2017

Double Mastectomy Linked to More Work Absences for Women with Early-Stage Breast Cancer

News

Double mastectomy, an aggressive surgical procedure to remove both breasts, increases the chances that early stage breast cancer patients will miss work for longer periods or stop working entirely, a ... Read more

October 11, 2017

Researchers Develop New Strategy to Target Breast Cancer Metastasis in Bones

News

A new method using small particles loaded with chemotherapy drugs is a viable approach to target breast cancer cells that have spread to the bones, according to a report that ... Read more

October 9, 2017

Synergys Awarded NCI Grant to Develop SYN001 for Triple-negative Breast Cancer

News

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded Synergys Biotherapeutics a grant to support the development of its antibody fusion molecule SYN001 for the treatment of triple negative breast cancer ... Read more

September 18, 2017September 18, 2017

MasSpec Pen Accurately Detects Cancer Cells During Surgery in Seconds

News

Researchers at the University of Texas at Austin developed an automated handheld device that accurately identifies cancerous tissue in as little as 10 seconds. The device, called MasSpec Pen, is designed ... Read more

June 8, 2017July 11, 2019

Response to Neratinib and Xeloda Combo Seen in Breast Cancer Patients with Brain Metastasis

News

Combining Puma Biotechnology’s candidate therapy PB272, also known as neratinib, with the chemotherapy drug Xeloda (capecitabine) appears to have therapeutic potential for patients with advanced HER2-positive breast cancer and brain metastasis, who were not previously treated with ... Read more

June 5, 2017June 7, 2017

Kisqali, Femara Combo Shows Promise in HR+/HER2- Advanced Breast Cancer Patients

News

The latest results from the Phase 3 MONALEESA-2 study showed that adding Novartis’ Kisqali (ribociclib) to ‎Femara (letrozole) for the treatment of breast cancer in certain postmenopausal women improves the time ... Read more